Your browser doesn't support javascript.
loading
Measuring Behavior in the Home Cage: Study Design, Applications, Challenges, and Perspectives.
Grieco, Fabrizio; Bernstein, Briana J; Biemans, Barbara; Bikovski, Lior; Burnett, C Joseph; Cushman, Jesse D; van Dam, Elsbeth A; Fry, Sydney A; Richmond-Hacham, Bar; Homberg, Judith R; Kas, Martien J H; Kessels, Helmut W; Koopmans, Bastijn; Krashes, Michael J; Krishnan, Vaishnav; Logan, Sreemathi; Loos, Maarten; McCann, Katharine E; Parduzi, Qendresa; Pick, Chaim G; Prevot, Thomas D; Riedel, Gernot; Robinson, Lianne; Sadighi, Mina; Smit, August B; Sonntag, William; Roelofs, Reinko F; Tegelenbosch, Ruud A J; Noldus, Lucas P J J.
Affiliation
  • Grieco F; Noldus Information Technology BV, Wageningen, Netherlands.
  • Bernstein BJ; Neurobiology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, United States.
  • Biemans B; Roche Innovation Center Basel, Basel, Switzerland.
  • Bikovski L; Myers Neuro-Behavioral Core Facility, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Burnett CJ; School of Behavioral Sciences, Netanya Academic College, Netanya, Israel.
  • Cushman JD; Nash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • van Dam EA; Neurobiology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, United States.
  • Fry SA; Noldus Information Technology BV, Wageningen, Netherlands.
  • Richmond-Hacham B; Neurobiology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, United States.
  • Homberg JR; Department of Anatomy and Anthropology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Kas MJH; Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands.
  • Kessels HW; Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, Netherlands.
  • Koopmans B; Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, Netherlands.
  • Krashes MJ; Sylics (Synaptologics BV), Amsterdam, Netherlands.
  • Krishnan V; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States.
  • Logan S; Laboratory of Epilepsy and Emotional Behavior, Baylor Comprehensive Epilepsy Center, Departments of Neurology, Neuroscience, and Psychiatry & Behavioral Sciences, Baylor College of Medicine, Houston, TX, United States.
  • Loos M; Department of Rehabilitation Sciences, College of Allied Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
  • McCann KE; Sylics (Synaptologics BV), Amsterdam, Netherlands.
  • Parduzi Q; Neurobiology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, United States.
  • Pick CG; Roche Innovation Center Basel, Basel, Switzerland.
  • Prevot TD; Department of Anatomy and Anthropology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Riedel G; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
  • Robinson L; The Dr. Miriam and Sheldon G. Adelson Chair and Center for the Biology of Addictive Diseases, Tel Aviv University, Tel Aviv, Israel.
  • Sadighi M; Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Smit AB; Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.
  • Sonntag W; Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.
  • Roelofs RF; Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands.
  • Tegelenbosch RAJ; Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, VU University Amsterdam, Amsterdam, Netherlands.
  • Noldus LPJJ; Department of Biochemistry & Molecular Biology, Center for Geroscience, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Front Behav Neurosci ; 15: 735387, 2021.
Article in En | MEDLINE | ID: mdl-34630052
ABSTRACT
The reproducibility crisis (or replication crisis) in biomedical research is a particularly existential and under-addressed issue in the field of behavioral neuroscience, where, in spite of efforts to standardize testing and assay protocols, several known and unknown sources of confounding environmental factors add to variance. Human interference is a major contributor to variability both within and across laboratories, as well as novelty-induced anxiety. Attempts to reduce human interference and to measure more "natural" behaviors in subjects has led to the development of automated home-cage monitoring systems. These systems enable prolonged and longitudinal recordings, and provide large continuous measures of spontaneous behavior that can be analyzed across multiple time scales. In this review, a diverse team of neuroscientists and product developers share their experiences using such an automated monitoring system that combines Noldus PhenoTyper® home-cages and the video-based tracking software, EthoVision® XT, to extract digital biomarkers of motor, emotional, social and cognitive behavior. After presenting our working definition of a "home-cage", we compare home-cage testing with more conventional out-of-cage tests (e.g., the open field) and outline the various advantages of the former, including opportunities for within-subject analyses and assessments of circadian and ultradian activity. Next, we address technical issues pertaining to the acquisition of behavioral data, such as the fine-tuning of the tracking software and the potential for integration with biotelemetry and optogenetics. Finally, we provide guidance on which behavioral measures to emphasize, how to filter, segment, and analyze behavior, and how to use analysis scripts. We summarize how the PhenoTyper has applications to study neuropharmacology as well as animal models of neurodegenerative and neuropsychiatric illness. Looking forward, we examine current challenges and the impact of new developments. Examples include the automated recognition of specific behaviors, unambiguous tracking of individuals in a social context, the development of more animal-centered measures of behavior and ways of dealing with large datasets. Together, we advocate that by embracing standardized home-cage monitoring platforms like the PhenoTyper, we are poised to directly assess issues pertaining to reproducibility, and more importantly, measure features of rodent behavior under more ethologically relevant scenarios.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Behav Neurosci Year: 2021 Document type: Article Affiliation country: Países Bajos

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Behav Neurosci Year: 2021 Document type: Article Affiliation country: Países Bajos